
Conformis CFMS
Quarterly report 2023-Q2
added 08-02-2023
Conformis DIO Ratio 2011-2026 | CFMS
Annual DIO Ratio Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 | 148 | 131 | 108 | 84.3 | 68 | 80.4 | 99.1 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 160 | 68 | 110 |
Quarterly DIO Ratio Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 | 227 | - | 178 | 150 | 144 | - | 155 | 139 | 154 | - | 136 | 136 | 121 | - | 114 | 110 | 91.2 | - | 93.9 | 87.1 | 78.6 | - | 75.4 | 68.5 | 68.3 | - | 84.6 | 80.2 | 78 | - | 94.4 | 92.2 | 93.4 | - | 95.5 | 49.4 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 | 49.4 | 113 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | ||
|
AxoGen
AXGN
|
226 | $ 32.95 | 6.12 % | $ 1.46 B | ||
|
Abiomed
ABMD
|
193 | - | - | $ 17.2 B | ||
|
Boston Scientific Corporation
BSX
|
184 | $ 98.65 | 0.01 % | $ 145 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
304 | $ 21.97 | - | $ 3.14 B | ||
|
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M | ||
|
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
213 | $ 3.46 | -2.81 % | $ 120 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 9.54 | 2.03 % | $ 685 M | ||
|
Bio-Rad Laboratories
BIO
|
237 | $ 324.09 | -0.43 % | $ 9.14 B | ||
|
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
216 | $ 53.01 | - | $ 7.9 K | ||
|
CONMED Corporation
CNMD
|
211 | $ 43.4 | -0.05 % | $ 1.34 B | ||
|
Abbott Laboratories
ABT
|
125 | $ 127.04 | - | $ 221 B | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 3.8 | 0.53 % | $ 142 M | ||
|
Electromed
ELMD
|
91.2 | $ 29.4 | - | $ 249 M | ||
|
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | ||
|
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | ||
|
InMode Ltd.
INMD
|
246 | $ 15.64 | - | $ 1.24 B | ||
|
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | ||
|
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | ||
|
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
10.1 | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | ||
|
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | ||
|
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M | ||
|
IRIDEX Corporation
IRIX
|
125 | $ 1.19 | 0.85 % | $ 19.2 M | ||
|
Align Technology
ALGN
|
83.8 | $ 166.81 | -0.51 % | $ 12.5 B | ||
|
IRadimed Corporation
IRMD
|
251 | $ 98.34 | 0.28 % | $ 1.25 B | ||
|
Accuray Incorporated
ARAY
|
164 | $ 0.87 | - | $ 89.4 M | ||
|
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
220 | $ 15.29 | - | $ 413 M | ||
|
FONAR Corporation
FONR
|
13.9 | $ 18.54 | - | $ 122 M | ||
|
OrthoPediatrics Corp.
KIDS
|
725 | $ 18.39 | -1.87 % | $ 424 M | ||
|
Globus Medical
GMED
|
266 | $ 90.54 | - | $ 12.3 B | ||
|
LivaNova PLC
LIVN
|
141 | $ 64.62 | 0.78 % | $ 3.5 B | ||
|
LENSAR
LNSR
|
179 | $ 11.53 | 0.7 % | $ 133 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 13.15 | 0.15 % | $ 1.01 B | ||
|
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | ||
|
Establishment Labs Holdings
ESTA
|
511 | $ 70.01 | - | $ 1.97 B |